Abstract: Proposed is a bioink supply system and, more particularly, proposed is a bioink supply system including: a hydrogel storage part; cell storage part; a mixing part configured to receive and mix a hydrogel and a cell solution from the hydrogel storage part and the cell storage part; a sensor part configured to measure a level of bioink inside a syringe; and a controller configured to receive a signal from the sensor part and maintain a constant level of the bioink inside the syringe, in which the mixing part supplies, to the syringe, the bioink prepared by mixing the hydrogel and the cell solution. The bioink supply system can continuously supply an active bioink to a syringe of a bioprinter during 3D bioprinting, and thus can continuously print large-scale biotissue, a plurality of organoids, organ-on-a-chip devices, etc.

Abstract: An electronic control suspension system for a vehicle is proposed. The electronic control suspension system includes a detection unit detecting information on a road in front of the vehicle, an electronic control suspension which damping force is controlled by current, and a control unit is configured to adjust the damping force of the electronic control suspension according to the information detected by the detection unit.

Abstract: Provided is a method and device for controlling a preparation instrument that prepares a detection composition used for detecting a target nucleic acid molecule in a specimen using an integrated instruction file.

Abstract: The present invention relates to a three-dimensional (3D) printing system for manufacturing an artificial blood vessel and a method for manufacturing an artificial blood vessel using the same, wherein a cylindrical support having a hollow 3D porous structure including a thermoplastic polymer is manufactured and vertically fixed, and a hydrogel divided into at least two sections is discharged into the support, thereby maintaining the structure and shape constantly even after printing and manufacturing an artificial blood vessel having a hollow multilayered structure.

Abstract: Provided is a method and device for controlling a preparation instrument that prepares a detection composition used for detecting a target nucleic acid molecule in a specimen using an integrated instruction file.

Abstract: An amplification data display method according to the present invention comprises the steps of: displaying a plate display area and an integrated data display area; displaying, the plate display area, plates where nucleic acid amplification reactions have been performed; and displaying amplification data in the integrated data display area, wherein: two or more plates are displayed in the plate display area; each of the plates includes a plurality of reaction wells; the amplification data are generated from the reaction wells by the nucleic acid amplification reactions; and amplification data for a plurality of reaction wells selected from the reaction wells of two or more of the displayed plates are displayed in the integrated data display area.

Abstract: The present invention provides a pharmaceutical composition in a powder form for providing wound protection, hemostasis, or anti-adhesion in the gastrointestinal tract, which comprises a certain mucoadhesive polymer; and a certain hygroscopic agent.

Abstract: Provided is a method for preventing or treating skin rash comprising administering to a subject in need thereof epidermal growth factor as an active ingredient. The skin rash includes a skin disorder caused by administering an epidermal growth factor receptor inhibitor, such as erlotinib, as an adverse event.

Abstract: The present invention provides a pharmaceutical composition in a powder form for providing wound protection, hemostasis, or anti-adhesion in the gastrointestinal tract, which comprises a certain mucoadhesive polymer; and a certain hygroscopic agent.

Abstract: There are disclosed racemic or enantiomerically enriched 3- or 4-substituted piperidine compounds represented by the following structural formula (I): or any of their isomers, or pharmaceutically acceptable salts thereof. Also disclosed are pharmaceutical compositions containing the subject compounds. The subject compounds are useful for the treatment of diseases of the central nervous system, particularly depression, anxiety and pain disorder.

Abstract: Racemic or enantiomerically enriched 3-substituted propanamine compounds represented by the following structural formula (I): or a pharmaceutically acceptable salt thereof are disclosed. Pharmaceutical compositions containing the subject compounds are also disclosed. The subject compounds are useful for the treatment of diseases of the central nervous system, such as depression, anxiety and pain disorders.

Abstract: Racemic or enantiomerically enriched 3-substituted propanamine compounds represented by the following structural formula (I): or a pharmaceutically acceptable salt thereof are disclosed. Pharmaceutical compositions containing the subject compounds are also disclosed. The subject compounds are useful for the treatment of diseases of the central nervous system, such as depression, anxiety and pain disorders.

Abstract: Racemic or enantiomerically enriched 3-substituted propanamine compounds represented by the following structural formula (I): or a pharmaceutically acceptable salt thereof are disclosed. Pharmaceutical compositions containing the subject compounds are also disclosed. The subject compounds are useful for the treatment of diseases of the central nervous system, such as depression, anxiety and pain disorders.

Abstract: Racemic or enantiomerically enriched 3-substituted propanamine compounds represented by the following structural formula (I): or a pharmaceutically acceptable salt thereof are disclosed. Pharmaceutical compositions containing the subject compounds are also disclosed. The subject compounds are useful for the treatment of diseases of the central nervous system, such as depression, anxiety and pain disorders.

Abstract: Disclosed are a method of producing a target protein in a biologically-active, soluble form in prokaryotic cells and polycistronic vectors therefor.

Abstract: There are disclosed racemic or enantiomerically enriched 3- or 4-substituted piperidine compounds represented by the following structural formula (I) or any of their isomers, or pharmaceutically acceptable salts thereof. Also disclosed are pharmaceutical compositions containing the subject compounds.

Abstract: In a method for generating activation energy and an apparatus thereof, in which energy of specific wavelength is generated continuously from a specific substance during a level of filtered energy restores to a normal state, by filtering the energy of the specific wavelength to the specific substance and so heightening the energy level, it is characterized by such a construction that an energy filtering equipment for filtering energy of specific frequency is constructed in an energy radiating equipment for emitting the energy of specific frequency filtered for a constant period when the energy of the specific frequency is filtered, and that in such construction, an installment of the energy filtering equipment and its inspection process, a conveyor system interlocked with the energy filtering equipment through a time controlling equipment, and a forwarding inspection process are combined with one another, wherein the energy filtering equipment is automatically controlled by a process controlling computer opera